General aspects of secondary prevention after myocardial infarction.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001026:Coronary Artery Bypass; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications; D006973:Hypertension / Q000150:complications; D009203:Myocardial Infarction / Q000401:mortality / Q000517:prevention & control* / Q000628:therapy; D010806:Physical Education and Training; D011379:Prognosis; D012008:Recurrence; D012306:Risk; D012907:Smoking / Q000150:complications
D000319:Adrenergic beta-Antagonists; D000925:Anticoagulants